Triptolide regulates T cell-mediated immunity via induction of CD11c low dendritic cell differentiation

Food and Chemical Toxicology

Volumn 50, Issue 7, 2012, Pages 2560-2564

  Yan, Yong Hong ^a   Shang, Pei Zhong ^a   Lu, Qing Jun ^a   Wu, Xu ^b  

^a 251 Hospital of PLA   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

CD11c high DCs; CD11c low DCs; Dendritic cell; Immunity; Triptolide

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD45RB ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRIPTOLIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFECT; DRUG MECHANISM; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; TH1 TH2 BALANCE;

ANTIGENS, CD11C; CELL DIFFERENTIATION; DENDRITIC CELLS; DITERPENES; EPOXY COMPOUNDS; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE CULTURE TEST, MIXED; PHENANTHRENES; T-LYMPHOCYTES;

MUS; TRIPTERYGIUM WILFORDII;

EID: 84861467728     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.04.033     Document Type: Article

References (13)

1. Chen B.J. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk. Lymphoma. 2001, 42:253-265.
2. Chen T., Xu H., Wang H.Q., Zhao Y., Zhu C.F., Zhang Y.H., Ji M.J., Hua Y.B., Wu W.X. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrowderived dendritic cells. Transplant. Proc. 2008, 40:3711-3713.
3. Gu W.Z., Chen R., Brandwein S., McAlpine J., Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide. Int. J Immunopharmacol. 1995, 17:351-356.
4. Liu Q.Y., Chen T., Chen H., Zhang M., Li N., Lu Z., Ma P., Cao X. Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation. Biochem. Biophys. Res. Commun. 2004, 319:980-986.
5. Liu J., Wu Q.L., Feng Y.H., Wang Y.F., Li X.Y., Zuo J.P. Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells. Acta. Pharmacol Sin. 2005, 26:223-227.
6. Liu Q.Y., Chen T., Chen G., Li N., Wang J.L., Ma P.C., Cao X.T. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-κB activation. Biochem. Biophys. Res. Commun. 2006, 345:1122-1130.
7. Liu Q.Y., Chen T., Chen G., Shu X., Sun A., Ma P., Lu L., Cao X. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol. Immunol. 2007, 44:2686-2696.
8. low dendritic cells in vitro. J. Ethnopharmacol. 2011, 136:457-464.
9. Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., Ng J.C., Kao P.N. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J. Biol. Chem. 1999, 274:13443-13450.
10. Qiu D., Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook f. Drugs R.D. 2003, 4:1-18.
11. Tao X.L., Sun Y., Dong Y., Xiao Y.L., Hu D.W., Shi Y.P., Zhu Q.L., Dai H., Zhang N.Z. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin. Med. J. 1989, 102:327-332.
12. Tao X., Davis L.S., Lipsky P.E. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis. Rheum. 1991, 34:1274-1281.
13. Zhu K.J., Shen Q.Y., Cheng H., Mao X.H., Lao L.M., Hao G.L. Triptolide affects the differentiation, maturation and function of human dendritic cells. Int. Immunopharmacol. 2005, 5:1415-1426.